Skip to content

A study comparing two iron supplements to improve hemoglobin levels in children with anemia

A Study to compare the efficacy of conventional iron and Liposomal iron in treatment of iron defieciency anemia - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102665
Enrollment
80
Registered
2026-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E611- Iron deficiency

Interventions

Intervention1: Conventional iron,Liposomal iron: 3mg/kg/day OD X 12 weeks ,1mg/kg/day OD x 12 weeks Intervention2: Conventional iron: 3mg/kg/day OD,oral for 12 weeks Intervention3: Liposomal iron: 1mg

Sponsors

Dr Isha upadhyay
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-Children aged 6 months to 18 years. 2-Children attending OPD or IPD of the Department of Pediatrics. 3-Diagnosed cases of nutritional iron deficiency anemia. 4-Diagnosis confirmed by hematological parameters (low hemoglobin with supportive iron indices). 5-Children whose parents/guardians give written informed consent. 6-Children who are willing and eligible for follow-up during the study period.

Exclusion criteria

Exclusion criteria: 1-Children with other causes of anemia, such as: Hemolytic anemia,Bone marrow failure syndromes 2-Children with history of acute blood loss. 3-Children who have received oral iron therapy or blood transfusion in the past 3 months. 4-Children with diseases affecting iron absorption such as:Celiac disease,Inflammatory bowel disease,History of bowel surgery,Chronic gastrointestinal infections 5-Children with serious chronic medical illnesses, including:Chronic kidney disease (CKD),Congenital heart disease (CHD),Chronic lung disease (CLD) 6-Children with malignancy of any type. 7-Children with known hypersensitivity or allergy to iron preparations. 8-Infants below 6 months of age.

Design outcomes

Primary

MeasureTime frame
Primary outcome is to look for improvement in the anemia status and compare it in both the groups.Timepoint: At baseline , 1 month , 3 months

Secondary

MeasureTime frame
NilTimepoint:

Countries

India

Contacts

Public ContactDr Isha upadhyay

Hind Institute of medical sciences

Utkarsh1003@gmail.com7985244354

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026